Enara Bio
TCR-based immunotherapies developer targeting novel dark antigens for cancer patients.
1
Funding Rounds
$32.5m
Money raised
Funding series
Funding Series Analysis
The company Enara Bio has raised a total of $32.5m in funding over 1 rounds.
Key Insights:
- Enara Bio Series B Round, October 2024: $32.5m
Enara Bio Series B Round, October 2024
$32.5m
Industries
Enara Bio is active in the following industries: